# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dorothea Lange (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML045-SYN-TD
- Date: 1957-08-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Ashford-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Six-month review of post-polio syndrome, falls, bone health, and reflux. **S**

## History of present illness

Ms. Lange is six months from the diagnosis of post-polio syndrome. She finished twelve weeks of physical therapy three months ago and does her home program four days a week. She has had no falls since the orthosis. She works in the field two days a week with a colleague carrying the tripod, rests the next day, and has less evening aching. She completed the eight-week omeprazole healing course and has stepped down to taking it only on days with symptoms, which is about four days a week; heartburn is controlled. She has had no difficulty swallowing, weight loss, or black stools. Dr. Haddad-Sorensen reviewed her in the neuromuscular clinic last week and found her strength unchanged. She has not had any procedure needing sedation since the endoscopy. **S**

| Element | Detail |
|---|---|
| Function | No falls; home exercise four days a week; two field days a week |
| Reflux | Healing course completed; omeprazole on about four days a week; symptoms controlled |
| Pain | 3 of 10 |
| Bone | Vitamin D taken daily; next zoledronic acid in April |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; weight up slightly |
| Musculoskeletal | Positive | Mild thigh aching after field days |
| Neurological | Negative | No new weakness |
| Respiratory | Negative | No breathlessness or morning headache |
| Gastrointestinal | Negative | Heartburn controlled; no difficulty swallowing |
| Psychiatric | Negative | Mood good; PHQ-9 2 |

6 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (1931 units) by mouth once daily **S**
- Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year **S**
- Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptoms **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 51 kg; BMI 22.1 kg/m². All vital signs are synthetic.

PHQ-9: 2; Pain (0 to 10): 3. All results are synthetic.

## Change since baseline

- PHQ-9: 6 at baseline, 2 at this visit **S**
- Pain (0 to 10): 6 at baseline, 3 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Neurological | Strength (MRC) unchanged from the baseline six months ago: left quadriceps 4/5, left hip abductors 4/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5, deltoids 4+/5 |
| Gait | Steady with the orthosis and cane; Timed Up and Go 11.2 seconds |
| Skin | No pressure marks from the orthosis |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-polio syndrome** (G14). Stable strength over six months, less pain (3 of 10), and less fatigue with pacing and exercise; no falls. She is working in the field again on her own terms. **S**
   - Continue the home program and pacing.
   - Spirometry and strength review at one year, sooner for breathlessness, swallowing trouble, or new weakness.
   - Review the orthosis yearly or if the knee buckles.
2. **Reflux esophagitis** (K21.00). Healed clinically; controlled on omeprazole taken on symptom days. Long-term proton pump inhibitor use should be at the lowest effective dose, which matters for her bones. **S**
   - Continue omeprazole on symptom days only.
   - Report difficulty swallowing, weight loss, or black stools.
3. **Osteoporosis** (M81.8). On zoledronic acid and vitamin D; no falls. **S**
   - Second infusion in April, with acetaminophen before and after.
   - DXA two years after the first.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Strength stable over six months; TUG 11.2 seconds |
| Survey | Pain score | Every visit | Completed today | Pain 3 of 10 |
| Survey | Depression screen (PHQ-9) | Periodically | Completed today | PHQ-9 2 |
| Imaging | Spirometry | Yearly or with symptoms | Up to date | Normal six months ago; due at one year |
| Examination | Sleep and breathing symptoms | Every visit | Completed today | Sleep refreshing; no morning headache |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing |
| Examination | Orthosis fit and skin check | Every visit | Completed today | Good fit |
| Self-management | Home exercise and pacing | Every visit | Completed today | Four days a week of home exercise; two field days with rest days |
| Examination | Fall review | Every visit | Completed today | No falls in six months |
| Medication safety | Proton pump inhibitor at the lowest effective dose | At each review | Completed today | Stepped down to symptom days only |
| Medication safety | Zoledronic acid: next dose checks | Before each infusion | Due | Calcium, vitamin D, creatinine, and dental status before the April infusion |
| Laboratory | 25-hydroxyvitamin D | After repletion, then yearly | Up to date | 34 ng/mL four months ago on 1931 units daily |
| Imaging | Bone density (DXA) | Every 2 years on treatment | Up to date | Next two years after the first scan |
| Laboratory | 24-hour urine calcium | At diagnosis | Due | Collection planned in the week before the yearly review |
| Examination | Height measurement | Yearly | Due | At the yearly review |

## Goal progress

- Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded. Outcome by 1957-02-25: Post-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathy. **S**
- No falls over the next six months. Outcome by 1957-08-17: No falls since the orthosis and cane; Timed Up and Go 11.2 seconds. **S**
- Keep working in the field at least two days a week, with planned rests, without exhaustion the next day. In progress; target 1957-12-31. **S**
- Establish the cause of the heartburn and control it on the lowest effective therapy. Outcome by 1957-05-18: Endoscopy showed grade B esophagitis without Barrett's esophagus; omeprazole restarted, symptoms controlled. **S**
- Replete vitamin D and start fracture-protective treatment. Outcome by 1957-04-20: Vitamin D 34 ng/mL; first zoledronic acid infusion given. **S**

## Guideline basis

- EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006), European Federation of Neurological Societies
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56 (2022), American College of Gastroenterology
- World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing 2022;51(9):afac205 (2022), World Falls Guidelines Task Force (Age and Ageing)
- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge

## Follow-up

- Adult preventive visit in six weeks. Post-polio syndrome and bone review at one year with spirometry, vitamin D, calcium, and creatinine, then the second zoledronic acid infusion. **S**
- Next scheduled visit 1957-09-28: adult preventive visit. **S**
